Volume Spike Investor

Baidu, Inc. (NASDAQ: BIDU) is running on word that Google is now much more likely than not about to close its China website.  At 8:45 AM EST we have seen 77,000 shares trade and the stock is up 3.8% at $571.43.  The old 52-week high is $559.47. Pepsico, Inc. (NYSE: PEP) is trading higher at [...]

Novo Nordisk (NYSE: NVO) Rose after the FDA approved Victoza for a type 2 diabetes treatment in some adults.  Victoza belongs to a drug class called the GLP-1 family of diabetes medications used to control blood sugar by increased insulin, and that family also includes Byetta from Eli Lilly & Co. and Amylin Pharmaceuticals Inc. [...]

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) was raised to overweight this morning by BGarclays as seen in our top ten analyst calls.  Apparently, shares are taking it to heart immediately.  At 8:18 AM EST we have seen 50,000 shares trade hands, yet shares are up over 10% at $13.80 after a $12.47 close.  The average volume [...]

Amylin Pharmaceuticals Inc. (Nasdaq: AMLN) shares fell nearly 5 percent to $12.69 on more than 100,000 shares traded after hours, and are ones to watch for a potential downside volume spike this morning. The company posted Q2 EPS last night of 36 cents a share, missing analyst expectations by a penny a share. Revenue fell 5.7 [...]

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has already come close to 2-times normal trading volume after a brokerage firm downgrade.  This also follows a large downward move from last week.   You can read the full details at BioHealthInvestor.com to see the fundamental reasoning. We have also seen some options trading in the near month(s) contracts, although [...]